Analisis Interaksi Obat Antidiabetik terhadap Clinical Outcome Pasien DM Tipe 2 di RS X Jambi

Authors

  • Rasmala Dewi Sekolah Tinggi Ilmu Kesehatan Harapan Ibu Jambi
  • Armini Hadriyati Sekolah Tinggi Ilmu Kesehatan Harapan Ibu Jambi
  • Euryke Novalisa Situngkir Sekolah Tinggi Ilmu Kesehatan Harapan Ibu Jambi

DOI:

https://doi.org/10.36565/jab.v14i1.898

Keywords:

clinical outcome, diabetes mellitus type 2, drug interactions

Abstract

Diabetes mellitus (DM) type 2  is a chronic disease that requires continuous treatment, resulting in drug interactions. Drug interactions are one of the drug related problems identified as drug therapy events that can affect the patient's clinical outcome. The aim of the research is to determine the number of potential drug interactions in type 2 DM patients and the relationship between drug interactions and clinical outcomes in the form of achieving blood glucose control targets. This research was conducted using a descriptive analytical method with a cross-sectional design. Data were collected on type 2 DM patients in outpatient care at Hospital Data analysis of the relationship between therapy and clinical outcomes used the chi-square test. The results of the study found that 41 patients (89%) experienced drug interactions, 5 patients (11%) did not experience drug interactions. Based on this data, 138 cases could be identified, consisting of 91 cases (66%) of pharmacodynamic interaction mechanisms, 46 cases (34%) of pharmacokinetics, with 18 cases (13%) of minor severity, 114 cases (83%) of moderate severity. and major in 6 cases (4%). The most frequent interactions were candesartan and lantus with 9 cases (7%) and candesartan and novorapid with 9 cases (7%). Patients achieved clinical outcomes for blood glucose in 22 patients (48%) and 24 patients (52%) achieved uncontrollable blood glucose clinical outcomes. The results of the analysis carried out stated that there was a relationship between drug interactions and patient clinical outcomes in the form of controlled blood glucose control targets, p-value <0.013.

Author Biographies

Rasmala Dewi, Sekolah Tinggi Ilmu Kesehatan Harapan Ibu Jambi

Farmasi

Armini Hadriyati, Sekolah Tinggi Ilmu Kesehatan Harapan Ibu Jambi

Farmasi

Euryke Novalisa Situngkir, Sekolah Tinggi Ilmu Kesehatan Harapan Ibu Jambi

Farmasi

References

American diabetes, C. (2019). Professional Practice Committee : Standards of Medical Care in Diabetes d 2019. American Diabetes Association, 42(January), 2019. https://doi.org/10.2337/dc19-SPPC01

Astuti, A., Sari, L. A., & Merdekawati, D. (2022). Perilaku Diit Pada Diabetes Mellitus Tipe 2.

Bala, D. F. S., Aditya, M., & Yulinda Cesa, F. (2023). Evaluasi Penggunaan Obat Antidiabetes Pada Pasien Diabetes Mellitus Tipe 2 Di Rumah Sakit Baptis Batu. Sainsbertek Jurnal Ilmiah Sains & Teknologi, 3(2), 9–18. https://doi.org/10.33479/sb.v3i2.215

Dasopang, E. S., Harahap, U., & Lindarto, D. (2015). Polifarmasi dan Interaksi Obat Pasien Usia Lanjut Rawat Jalan dengan Penyakit Metabolik Polipharmacy and Drug Interactions in Elderly Patients with Metabolic Diseases. 4(4). https://doi.org/10.15416/ijcp.2015.4.4.235

Deni, D. I., Ismonah, I., & Handayani, P. A. (2023). Hubungan Self Efficacy Dengan Self Care Management Penderita Diabetes Mellitus Tipe 2 Di Wilayah Binaan Puskesmas Karangayu. Jurnal Perawat Indonesia, 6(3), 1234–1248. https://doi.org/10.32584/jpi.v6i3.1915

Fatmawati, B. R., Arifin, Z., Sukma Purqoti, D. N., & Ilham, I. (2023). Hubungan Health Locus Of Control Dengan Self-Care Behavior Pasien Diabetes Mellitus Tipe 2. Surya Medika: Jurnal Ilmiah Ilmu Keperawatan Dan Ilmu Kesehatan Masyarakat, 18(1), 41–47. https://doi.org/10.32504/sm.v18i1.768

Hardianto, D. (2020). Telaah komprehensif diabetes melitus: klasifikasi, gejala, diagnosis, pencegahan, dan pengobatan. Jurnal Bioteknologi & Biosains Indonesia, 7.

Isnani, N., Muliyani, Zaini, M., & Wardhani, P. S. (2022). Evaluasi Drug Related Problems Penggunaan Obat Antidiabetes Pada Pasien Diabetes Melitus Tipe 2 Di Instalasi Farmasi Rawat Inap Rumah Sakit Tk.Iii Dr. R. Soeharsono. Jurnal Insan Farmasi Indonesia, 5(2), 240–248.

Lestari, Zulkanain, & Sijid, S. A. (2021). Diabetes Melitus : Review Etiologi , Patofisiologi , Gejala , Penyebab , Cara Pemeriksaan , Cara Pengobatan dan Cara Pencegahan. Prosiding Biologi Achieving the Sustainable Development Goals with Biodiversity in Confronting Climate Change, 7(November), 237–241. http://journal.uin-alauddin.ac.id/index.php/psb%0ADiabetes

Perkeni. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021.

Pradifta, R. (2019). Kajian Interaksi Obat Antidiabetik Dengan Obat Lain Pada Pasien Diabetes Mellitus Rawat Inap Di Rsud Dr. Soekardjo Tasikmalaya. Journal of Pharmacopolium, 2(2), 88–93. https://doi.org/10.36465/jop.v2i2.486

Rahmawaty, A., & Hidayah, P. H. (2020). Hubungan Drug Related Problems (DRPs) Kategori Interaksi Obat pada Penggunaan Obat Pasien Diabetes Mellitus Tipe 2. Cendekia Journal of Pharmacy, 4(1), 80–88. https://doi.org/10.31596/cjp.v4i1.76

Ratnasari, P. M. D., Andayani, T. M., & Endarti, D. (2020). Analisis Outcome Klinis Berdasarkan Kualitas Hidup dan Biaya Medik Langsung Pasien Diabetes Melitus Tipe 2. Jurnal Sains Farmasi & Klinis, 7(1), 15. https://doi.org/10.25077/jsfk.7.1.15-22.2020

Risal, A., Khusna, K., & Pambudi, R. S. (2021). Interaksi Obat Hipoglikemia Oral (OHO) dengan Obat Lain pada Pasien Diabetes Mellitus Tipe II berdasarkan Farmakokinetik dan Farmakodinamik di Puskesmas Sangkrah. 1st E-Proceeding Senriabdi 2021, 1(1), 979–990.

Rochmawati, N. F., Riyanto, W. H., & Nuraini, I. (2018). Hubungan Tingkat Pendidikan, Usia, dan Pengalaman Kerja Terhadap Pendapatan Pekerja Wanita pada Industri Kerajinan Dompet Ida Collection di Desa Pulo Kecamatan Tempeh Kabupaten Lumajang. Jurnal Ilmu Ekonomi, 2, 399–408.

Saibi, Y., Hasan, D., Safitri, B., & Anwar, V. A. (2020). Potensi Hipoglikemia Dan Hiperglikemia Pada Pasien Diabetes Melitus Tipe 2 Akibat Interaksi Obat. Jurnal Ilmiah Ibnu Sina (JIIS) Ilmu Farmasi Dan Kesehatan, 5(2), 258–267. https://doi.org/10.36387/jiis.v5i2.468

Sulastri, SKp, M. K. (2022). Buku Pintar Perawatan Diabetes Melitus (Aplikasi Standar Diagnosa Keperawatan Indonesia (SDKI), Standar Luaran Keperawatan Indonesia (SLKI), Standar Intervensi Keperawatan Indonesia (SIKI).

Widiasari, K. R., Wijaya, I. M. K., & Suputra, P. A. (2021). Diabetes Melitus Tipe 2: Faktor Risiko, Diagnosis, Dan Tatalaksana. Ganesha Medicine, 1(2), 114. https://doi.org/10.23887/gm.v1i2.40006

Yuliasari, I., Anggriani, Y., & Utami, H. (2022). Klinik berdasarkan pemilihan jenis insulin. Farmasains, 9(2), 87-95.

Downloads

Published

2025-03-31

Issue

Vol. 14 No. 1 (2025): Maret

Section

Articles

License

Copyright (c) 2025 Jurnal Akademika Baiturrahim Jambi

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).